RU95102777A - Способ лечения реперфузного повреждения и "оглушения" миокарда - Google Patents

Способ лечения реперфузного повреждения и "оглушения" миокарда

Info

Publication number
RU95102777A
RU95102777A RU95102777/14A RU95102777A RU95102777A RU 95102777 A RU95102777 A RU 95102777A RU 95102777/14 A RU95102777/14 A RU 95102777/14A RU 95102777 A RU95102777 A RU 95102777A RU 95102777 A RU95102777 A RU 95102777A
Authority
RU
Russia
Prior art keywords
treatment
myocardial damage
deafening
reperfuse
carboxamides
Prior art date
Application number
RU95102777/14A
Other languages
English (en)
Inventor
С.Кистис Элизабет
Us]
Original Assignee
Пфайзер Инк. (US)
Пфайзер Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Пфайзер Инк. (US), Пфайзер Инк. filed Critical Пфайзер Инк. (US)
Publication of RU95102777A publication Critical patent/RU95102777A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретение относится к применению некоторых 3-замещенных 2-оксиндол-1-карбоксамидов и их фармацевтически приемлемых основных солей для лечения или предупреждения у млекопитающих, включая человека, повреждения миокарда, вызываемого ишемией, или повреждения миокарда, медиированного цитокином.

Claims (1)

  1. Изобретение относится к применению некоторых 3-замещенных 2-оксиндол-1-карбоксамидов и их фармацевтически приемлемых основных солей для лечения или предупреждения у млекопитающих, включая человека, повреждения миокарда, вызываемого ишемией, или повреждения миокарда, медиированного цитокином.
RU95102777/14A 1994-03-02 1995-03-01 Способ лечения реперфузного повреждения и "оглушения" миокарда RU95102777A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20484494A 1994-03-02 1994-03-02
US08/204844 1994-03-02

Publications (1)

Publication Number Publication Date
RU95102777A true RU95102777A (ru) 1997-01-20

Family

ID=22759686

Family Applications (1)

Application Number Title Priority Date Filing Date
RU95102777/14A RU95102777A (ru) 1994-03-02 1995-03-01 Способ лечения реперфузного повреждения и "оглушения" миокарда

Country Status (11)

Country Link
EP (1) EP0679396A1 (ru)
JP (1) JPH07267859A (ru)
KR (1) KR950026521A (ru)
CN (1) CN1112919A (ru)
AU (1) AU1355095A (ru)
CA (1) CA2143544A1 (ru)
FI (1) FI950951A (ru)
HU (1) HUT71896A (ru)
IL (1) IL112747A0 (ru)
RU (1) RU95102777A (ru)
ZA (1) ZA951679B (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6534651B2 (en) 2000-04-06 2003-03-18 Inotek Pharmaceuticals Corp. 7-Substituted isoindolinone inhibitors of inflammation and reperfusion injury and methods of use thereof
PT1965831E (pt) * 2005-12-21 2011-10-19 Pharming Intellectual Pty Bv Uso de inibidor c1 para a prevenção da lesão isquémia-reperfusão

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
EP0292699B1 (en) * 1987-04-24 1994-03-23 Abbott Laboratories Urea based lipoxygenase inhibiting compounds
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
EP0533837A4 (en) * 1990-06-12 1994-11-17 Smithkline Beecham Corp Inhibition of 5-lipoxygenase and cyclooxygenase pathway mediated diseases
CA2098177A1 (en) * 1990-12-13 1992-06-13 Jerry L. Adams Csaids
US5140047A (en) * 1991-05-03 1992-08-18 Smithkline Beecham Corporation Lipoxygenase inhibitors
FR2677477B1 (fr) * 1991-06-06 1993-08-20 Bellon Labor Sa Roger Nouveaux derives de l'oxazole leur preparation, leur utilisation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
ZA951679B (en) 1996-09-02
KR950026521A (ko) 1995-10-16
CN1112919A (zh) 1995-12-06
HUT71896A (en) 1996-02-28
HU9500636D0 (en) 1995-04-28
IL112747A0 (en) 1995-05-26
CA2143544A1 (en) 1995-09-03
FI950951A0 (fi) 1995-03-01
JPH07267859A (ja) 1995-10-17
AU1355095A (en) 1995-09-07
EP0679396A1 (en) 1995-11-02
FI950951A (fi) 1995-09-03

Similar Documents

Publication Publication Date Title
TW262461B (ru)
RU94020410A (ru) Способ лечения или профилактики рвоты у млекопитающих и человека с использованием некоторых хинуклидиновых, пиперидиновых, азанорборнановых, этилендиаминовых производных и родственных им соединений
ES2167377T3 (es) Derivados de piridina farmacologicamente activos y procedimientos para la preparacion de los mismos.
RU95114376A (ru) Нитроэфиры, обладающие фармакологической активностью, и способ их получения
DK0585328T3 (da) Substituerede 3-aminoquinuclidiner
RU93053493A (ru) Сульфатная соль (2:1)-3-[2-(диметиламино)этил]-n-метил-1н-индол-5-метансульфонамида и ее фармацевтически приемлемые сольваты, способ их получения, фармацевтические композиции на их основе, их применение в терапии, способ лечения головной боли
RU94040170A (ru) Изохинолины
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
FI925342A0 (fi) Menetelmä terapeuttisesti aktiivisen (+)- -(2,3-dimetoksifenyyli)-1-/2-(4-fluorifenyyli)etyyli/-4-piperidiinimetanolin valmistamiseksi
MC2078A1 (fr) Emploi d'alezastine comme matiere active contre le psoriasis et des maladies inflammatoires
DE69523155D1 (de) Benzimidazolonderivate mit zentraler dopaminerger aktivität
DE59409735D1 (de) ALKOXYALKYLCARBAMATE VON IMIDAZO[1,2-a]PYRIDINEN
MX9403088A (es) Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso.
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
DE69530988D1 (de) Benzimidazolderivate mit dopaminerger wirkung
IT1276162B1 (it) Geranilgeranil-derivati,procedimento per la loro preparazione e relative composizioni farmaceutiche
NO982863L (no) Nye forbindelser med analgetisk effekt
RU95102777A (ru) Способ лечения реперфузного повреждения и "оглушения" миокарда
ATE110714T1 (de) Derivate von hydroxaminsäure die lipoxygenase hemmen.
ES2148600T3 (es) Derivados de indol sustituidos.
RU94028126A (ru) Средство, обладающее иммуномодулирующей активностью
BR0015424A (pt) Análogos de ácido hidroxieicosatetraenóico e, métodos de seu uso em tratamento de distúrbios de olho seco
RU94031622A (ru) Гидрофильный бальзам для лечения и профилактики чесотки
RU93051046A (ru) Способ борьбы с аскосферозом и гнильцовыми болезнями пчел